Cutler Group LP Intra Cellular Therapies, Inc. Call Options Transaction History

Cutler Group LP

$307 Million
Q1 2024

Call Options

22 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 Apr 19, 2024	BUY	$64.37 - $75.65 $38,622 - $45,390	600 New	600 $2,000
Q3 2022 Oct 25, 2022	SELL	$42.7 - $59.99 $72,590 - $101,983	-1,700 Reduced 36.17%	3,000 $1,000
Q2 2022 Aug 04, 2022	SELL	$43.0 - $65.64 $223,600 - $341,328	-5,200 Reduced 52.53%	4,700 $23,000
Q1 2022 Apr 14, 2022	BUY	$38.74 - $62.09 $236,314 - $378,749	6,100 Added 160.53%	9,900 $59,000
Q4 2021 Jan 18, 2022	BUY	$35.2 - $53.42 $98,560 - $149,576	2,800 Added 280.0%	3,800 $39,000
Q3 2021 Oct 26, 2021	SELL	$28.72 - $42.49 $261,352 - $386,659	-9,100 Reduced 90.1%	1,000 $8,000
Q2 2021 Jul 19, 2021	BUY	$29.3 - $44.5 $263,700 - $400,500	9,000 Added 818.18%	10,100 $22,000
Q1 2021 Apr 26, 2021	SELL	$30.8 - $39.51 $61,600 - $79,020	-2,000 Reduced 64.52%	1,100 $8,000
Q4 2020 Jan 21, 2021	SELL	$23.34 - $32.22 $44,346 - $61,218	-1,900 Reduced 38.0%	3,100 $34,000
Q3 2020 Oct 27, 2020	SELL	$17.61 - $31.86 $70,440 - $127,440	-4,000 Reduced 44.44%	5,000 $25,000
Q2 2020 Jul 22, 2020	BUY	$14.35 - $26.64 $110,495 - $205,128	7,700 Added 592.31%	9,000 $46,000
Q1 2020 May 07, 2020	SELL	$12.31 - $33.12 $487,476 - $1.31 Million	-39,600 Reduced 96.82%	1,300 $6,000
Q4 2019 Feb 06, 2020	BUY	$7.26 - $38.49 $205,458 - $1.09 Million	28,300 Added 224.6%	40,900 $378,000
Q3 2019 Oct 28, 2019	BUY	$7.47 - $14.03 $41,085 - $77,165	5,500 Added 77.46%	12,600 $4,000
Q2 2019 Aug 09, 2019	BUY	$10.65 - $14.29 $53,250 - $71,450	5,000 Added 238.1%	7,100 $18,000
Q1 2019 May 10, 2019	SELL	$10.9 - $14.09 $208,190 - $269,119	-19,100 Reduced 90.09%	2,100 $1,000
Q4 2018 Feb 05, 2019	BUY	$10.36 - $20.96 $99,456 - $201,216	9,600 Added 82.76%	21,200 $5,000
Q3 2018 Nov 07, 2018	BUY	$17.77 - $22.9 $10,662 - $13,740	600 Added 5.45%	11,600 $50,000
Q2 2018 Aug 10, 2018	BUY	$17.33 - $23.4 $31,193 - $42,120	1,800 Added 19.57%	11,000 $30,000
Q1 2018 May 11, 2018	SELL	$15.16 - $25.49 $48,512 - $81,568	-3,200 Reduced 25.81%	9,200 $48,000
Q4 2017 Jan 17, 2018	SELL	$14.27 - $16.79 $586,497 - $690,069	-41,100 Reduced 76.82%	12,400 $23,000
Q3 2017 Oct 17, 2017	BUY	$10.77 - $22.1 $576,195 - $1.18 Million	53,500	53,500 $100,000

Others Institutions Holding ITCI

# of Institutions

378

Shares Held

84.7M

Call Options Held

319K

Put Options Held

143K

Vanguard Group Inc Valley Forge, PA

9.63M
Shares

$834 Million
0.01% of portfolio
Black Rock Inc. New York, NY

6.32M
Shares

$547 Million
0.01% of portfolio
Jpmorgan Chase & CO New York, NY

5.29M
Shares

$458 Million
0.03% of portfolio
Wasatch Advisors Inc Salt Lake City, UT

3.85M
Shares

$333 Million
1.4% of portfolio
Avoro Capital Advisors LLC New York, NY

3.05M
Shares

$264 Million
3.36% of portfolio

View Full List

About Intra-Cellular Therapies, Inc.

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $8.17B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

More about ITCI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Account